Alzheimer's disease-associated β-Amyloid does not protect against Herpes Simplex Virus 1 infection in the mouse brain
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Author
Bocharova, OlgaPandit, Narayan P
Molesworth, Kara
Fisher, Aidan
Mychko, Olga
Makarava, Natallia
Baskakov, Ilia V
Date
2021-05-28Journal
Journal of Biological ChemistryPublisher
Elsevier Inc.Type
Article
Metadata
Show full item recordAbstract
Alzheimer's disease (AD) is a devastating fatal neurodegenerative disease. An alternative to the amyloid cascade hypothesis is that a viral infection is key to the etiology of late-onset AD, with β-amyloid (Aβ) peptides playing a protective role. In the current study, young 5XFAD mice that overexpress mutant human amyloid precursor protein with the Swedish, Florida, and London familial AD mutations were infected with one of two strains of herpes simplex virus 1 (HSV-1), 17syn+ and McKrae, at three different doses. Contrary to previous work, 5XFAD genotype failed to protect mice against HSV-1 infection. The region- and cell-specific tropisms of HSV-1 were not affected by the 5XFAD genotype, indicating that host-pathogen interactions were not altered. 7- to 10-month old 5XFAD animals in which extracellular Aβ aggregates were abundant showed slightly better survival rate relative to their wild type (WT) littermates, although the difference was not statistically significant. In these 5XFAD mice, HSV-1 replication centers were partially excluded from the brain areas with high densities of Aβ aggregates. Aβ aggregates were free of HSV-1 viral particles, and the limited viral invasion to areas with a high density of Aβ aggregates was attributed to phagocytic activity of reactive microglia. In the oldest mice (12- to 15-months old), the survival rate did not differ between 5XFAD and WT littermates. While the current study questions the antiviral role of Aβ, it neither supports nor refutes the viral etiology hypothesis of late-onset AD.Rights/Terms
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.Keyword
5XFAD miceAlzheimer’s disease
Amyloid Precursor Protein
Aβ aggregates
astrocytes
herpes simplex virus 1
microglia
Identifier to cite or link to this item
http://hdl.handle.net/10713/15936ae974a485f413a2113503eed53cd6c53
10.1016/j.jbc.2021.100845
Scopus Count
Collections
Related articles
- 1950 MHz Electromagnetic Fields Ameliorate Aβ Pathology in Alzheimer's Disease Mice.
- Authors: Jeong YJ, Kang GY, Kwon JH, Choi HD, Pack JK, Kim N, Lee YS, Lee HJ
- Issue date: 2015
- Amyloid-β and p-Tau Anti-Threat Response to Herpes Simplex Virus 1 Infection in Primary Adult Murine Hippocampal Neurons.
- Authors: Powell-Doherty RD, Abbott ARN, Nelson LA, Bertke AS
- Issue date: 2020 Apr 16
- Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
- Authors: Hüttenrauch M, Baches S, Gerth J, Bayer TA, Weggen S, Wirths O
- Issue date: 2015
- Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.
- Authors: Guzmán EA, Bouter Y, Richard BC, Lannfelt L, Ingelsson M, Paetau A, Verkkoniemi-Ahola A, Wirths O, Bayer TA
- Issue date: 2014 Apr 2